Literature DB >> 15218280

Can we predict early recurrence in acute stroke?

Enrique C Leira1, Ku-Chou Chang, Patricia H Davis, William R Clarke, Robert F Woolson, Michael D Hansen, Harold P Adams.   

Abstract

BACKGROUND: The prevention of early recurrent stroke, which worsens outcomes after a cerebral infarction, is a major objective for acute stroke therapy. The ability to predict which patients are at risk for early recurrence would be useful for both the management and design of clinical trials.
METHODS: Using the prospective database with the 1,266 stroke patients admitted in the TOAST study, we analyzed all the patients who had suffered either a transient ischemic attack (TIA) or a recurrent stroke within 3 months after stroke, and their possible association with 20 selected clinical variables. Both univariate and stepwise regression analyses were performed.
RESULTS: Sixty-two patients (4.9%) had a second stroke, and 47 patients (3.7%) had at least one TIA. No particular high-risk period was observed. Early recurrent stroke was associated with the large artery atherosclerosis subtype. A prior history of TIA increased the odds for recurrent stroke (OR = 2.52; 1.16-5.46) or poststroke TIA (OR = 3.46; 1.59-7.48). In addition, patients who had a TIA after the stroke had a 17% chance of having an early recurrent stroke, as compared with 4.4% among those that did not (p = 0.001).
CONCLUSION: Our present ability to identify patients at risk for early recurrence based on baseline clinical features remains limited. While the presence of TIA before or after the stroke denotes a subgroup of acute stroke patients at higher risk for early recurrence in the first 3 months, no other factors reliably identify high-risk patients.

Entities:  

Mesh:

Year:  2004        PMID: 15218280     DOI: 10.1159/000079267

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Does race predict stroke readmission? An analysis using the truncated negative binomial model.

Authors:  Byron S Kennedy
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

2.  A score to predict early risk of recurrence after ischemic stroke.

Authors:  H Ay; L Gungor; E M Arsava; J Rosand; M Vangel; T Benner; L H Schwamm; K L Furie; W J Koroshetz; A G Sorensen
Journal:  Neurology       Date:  2009-12-16       Impact factor: 9.910

3.  Cilostazol reduces PAC-1 expression on platelets in ischemic stroke.

Authors:  Su-Yun Lee; Myong-Jin Kang; Jae-Kwan Cha
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

4.  Costs and outcomes of noncardioembolic ischemic stroke in a managed care population.

Authors:  Nicole M Engel-Nitz; Stephen D Sander; Carolyn Harley; Gabriel Gomez Rey; Hemal Shah
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

5.  Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study.

Authors:  J Castillo; J Alvarez-Sabín; E Martínez-Vila; J Montaner; T Sobrino; J Vivancos
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

6.  Impact of Smoking Status on Stroke Recurrence.

Authors:  Jingjing Chen; Shun Li; Kuo Zheng; Huaiming Wang; Yi Xie; Pengfei Xu; Zhengze Dai; Mengmeng Gu; Yaqian Xia; Min Zhao; Xinfeng Liu; Gelin Xu
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

7.  Cardiac rehabilitation adapted to transient ischaemic attack and stroke (CRAFTS): a randomised controlled trial.

Authors:  Olive Lennon; Catherine Blake
Journal:  BMC Neurol       Date:  2009-02-23       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.